» Articles » PMID: 33279501

A Nomogram to Early Predict Isolation Length for Non-severe COVID-19 Patients Based on Laboratory Investigation: A Multicenter Retrospective Study in Zhejiang Province, China

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 2020 Dec 6
PMID 33279501
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Majority coronavirus disease 2019 (COVID-19) patients are classified as mild and moderate (non-severe) diseases. We aim to develop a model to predict isolation length for non-severe patients.

Methods: Among 188 non-severe patients, 96 patients were enrolled as training cohort to identify factors associated with isolation length via Cox regression model and develop a nomogram. Other 92 patients formed as validation cohort to validate nomogram. Concordance index (C-index), area under the curve (AUC) and calibration curves were used to evaluated nomogram.

Results: Increasing absolute eosinophil count (AEC) after admission was correlated with shorter isolation length (P = 0.02). Baseline activated partial thromboplastin time (APTT) > 30 s was correlated with longer isolation length (P = 0.03). A nomogram to predict isolation probability at 11-, 16- and 21-day was developed and validated. The C-indices of training and validation cohort were 0.604 and 0.682 respectively. Both cohorts showed a good discriminative ability (AUC, 11-day: 0.646 vs 0.730; 16-day: 0.663 vs 0.750; 21-day: 0.711 vs 0.783; respectively) and calibration power.

Conclusions: Baseline APTT and dynamic change of AEC were two significant factors associated with isolation length of non-severe patients. Nomogram could predict isolation probability for each patient to estimate appropriate quarantine length.

Citing Articles

Development and validation of nomograms to predict clinical outcomes of preeclampsia.

Xia Y, Wang Y, Yuan S, Hu J, Zhang L, Xie J Front Endocrinol (Lausanne). 2024; 15:1292458.

PMID: 38549768 PMC: 10972945. DOI: 10.3389/fendo.2024.1292458.


Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China.

Jiang J, Zhong W, Huang W, Gao Y, He Y, Li X Ther Clin Risk Manag. 2022; 18:579-591.

PMID: 35607424 PMC: 9123913. DOI: 10.2147/TCRM.S361936.

References
1.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

2.
Liu X, Zhou H, Zhou Y, Wu X, Zhao Y, Lu Y . Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J Infect. 2020; 81(1):e95-e97. PMC: 7162771. DOI: 10.1016/j.jinf.2020.04.008. View

3.
Musa S, Zhao S, Wang M, Habib A, Mustapha U, He D . Estimation of exponential growth rate and basic reproduction number of the coronavirus disease 2019 (COVID-19) in Africa. Infect Dis Poverty. 2020; 9(1):96. PMC: 7365306. DOI: 10.1186/s40249-020-00718-y. View

4.
Liang W, Zhang L, Jiang G, Wang Q, Liu L, Liu D . Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015; 33(8):861-9. DOI: 10.1200/JCO.2014.56.6661. View

5.
LeMessurier K, Samarasinghe A . Eosinophils: Nemeses of Pulmonary Pathogens?. Curr Allergy Asthma Rep. 2019; 19(8):36. PMC: 6993982. DOI: 10.1007/s11882-019-0867-1. View